Zoledronic acid compared with pamidronate in patients with prostate cancer and bone metastases: Effects on skeletal complications and bone markers

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [1] Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer
    Hilton, J. F.
    Clemons, M.
    Pond, G.
    Zhao, H.
    Mazzarello, S.
    Vandermeer, L.
    Addison, C. L.
    [J]. JOURNAL OF BONE ONCOLOGY, 2018, 10 : 6 - 13
  • [2] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    不详
    [J]. BREAST, 2005, 14 : S45 - S46
  • [3] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    Rosen, L.
    Gordon, D.
    Chen, Y. M.
    [J]. CANCER TREATMENT REVIEWS, 2006, 32 : S43 - S43
  • [4] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    不详
    [J]. BREAST, 2005, 14 : S44 - S44
  • [5] Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastases
    Saad, Fred
    Chen, Yin-Miao
    Gleason, Donald M.
    Chin, Joseph
    [J]. CLINICAL GENITOURINARY CANCER, 2007, 5 (06) : 390 - 396
  • [6] Use of zoledronic acid in patients with prostate cancer bone metastases: control of pain and musculoskeletal complications
    Paparella, Stefano
    Finkelberg, Elisabetta
    Varisco, Daniela
    Tondelli, Elena
    Rocco, Francesco
    [J]. UROLOGIA JOURNAL, 2011, 78 (04) : 300 - 304
  • [7] Zoledronic acid reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer
    Kohno, N
    Aogi, K
    Minami, H
    Nakamura, S
    Asaga, T
    Iino, Y
    Watanabe, T
    Goessl, C
    Ohashi, Y
    Takashima, S
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S133 - S133
  • [8] Long-term reduction of bone pain and skeletal morbidity with zoledronic acid in patients with prostate cancer and bone metastases
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 145 - 145
  • [9] Bone Turnover Markers as Predictors of Mortality Risk in Prostate Cancer Patients with Bone Metastases Following Treatment with Zoledronic Acid
    Jung, Klaus
    Miller, Kurt
    Wirth, Manfred
    Albrecht, Michael
    Lein, Michael
    [J]. EUROPEAN UROLOGY, 2011, 59 (04) : 604 - 612
  • [10] Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases
    Hortobagyi, GN
    Theriault, RL
    Porter, L
    Blayney, D
    Lipton, A
    Sinoff, C
    Wheeler, H
    Simeone, JF
    Seaman, J
    Knight, RD
    Heffernan, M
    Reitsma, DJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24): : 1785 - 1791
12345